Altermune, LLC
Records under this name other than patents Altermune, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 6 of 6 · Back to Altermune, LLC
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,190,121 | Aptamers against EGFR and therapeutic uses thereof Formerly held In force · From the USPTO record | In force | From the USPTO record | |
| US 7,422,746 | Chemically programmable immunity Formerly held Term ended Term ended Jun 22, 2022 · From the USPTO record | Term ended | Term ended Jun 22, 2022 | From the USPTO record |
| US 7,645,743 | Chemically programmable immunity Formerly held Term ended Term ended Sep 19, 2021 · From the USPTO record | Term ended | Term ended Sep 19, 2021 | From the USPTO record |
| US 8,236,321 | Chemically programmable immunity Formerly held Term ended Term ended Jan 2, 2021 · From the USPTO record | Term ended | Term ended Jan 2, 2021 | From the USPTO record |
| US 7,850,975 | Chemically programmable immunity Formerly held Term ended Ended no later than Dec 21, 2020 · From the USPTO record | Term ended | Ended no later than Dec 21, 2020 | From the USPTO record |
| US 8,263,082 | Chemically programmable immunity Formerly held Term ended Term ended Dec 21, 2020 · From the USPTO record | Term ended | Term ended Dec 21, 2020 | From the USPTO record |